Literature DB >> 7093918

The thin malignant melanoma: changing patterns of epidemiology and treatment.

R Shafir, J Hiss, H Tsur, J J Bubis.   

Abstract

In the past few years a change has been noticed in the behavior of cutaneous malignant melanoma, with higher cure and survival rates. A retrospective review of all cases of primary cutaneous malignant melanoma during the years 1970-1979 in Chaim Sheba Medical Center reveals a possible explanation for this. The microscopic findings were reevaluated, diagnosis confirmed, and thickness of the tumor measured in millimeters. The number of cases diagnosed rose from eight in 1970 to 45 in 1979. A constant rise in number of thin melanomas (less than 0.75 mm in depth) was noticed. The percentage of thin melanoma rose from 11.1% of all melanomas in 1970 to 57.7% in 1979. Greater public and medical awareness of the danger of pigmented cutaneous lesions has probably triggered an earlier diagnosis of melanoma. Each suspected lesion is completely excised with a 1-cm free margin. No further excision is undertaken if a thin melanoma is diagnosed (excluding the more malignant regressing melanoma) on frozen section. Of the patients seen in 1979, 57% were spared wide excision and general anesthesia.

Entities:  

Mesh:

Year:  1982        PMID: 7093918     DOI: 10.1002/1097-0142(19820815)50:4<817::aid-cncr2820500434>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Authors:  H J Wanebo; P H Cooper; R W Hagar
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

2.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

Review 3.  Trends in cancer survival and mortality rates.

Authors:  J Pontén; H O Adami; P Sparén
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

4.  Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.

Authors:  S Kruijff; E Bastiaannet; A B Francken; M Schaapveld; M van der Aa; H J Hoekstra
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

5.  Period and cohort factors in the incidence of malignant melanoma in the state of Connecticut.

Authors:  J J Collins; N Devine
Journal:  Environ Health Perspect       Date:  1984-06       Impact factor: 9.031

6.  Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.

Authors:  M Thörn; P Sparén; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

7.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.